Professional Overview
Sam Sharifi is a seasoned biotech professional, currently serving as Chief Scientific Officer & Co-founder at multiple organizations, including Matter Bio, Mutagentech, and Loki Therapeutics, based in Leipzig, Saxony, Germany. His key expertise areas include biotechnology, scientific project management, and research, with a strong industry focus on longevity biotech and scientific research.
Experience Summary
Current Role
As Chief Scientific Officer & Co-founder at Matter Bio, Mutagentech, and Loki Therapeutics, Sam's key responsibilities include overseeing scientific research and development, managing projects, and contributing to the strategic growth of the companies. His achievements in these roles include driving innovation, building and managing high-performing teams, and contributing to the development of novel biotechnological solutions.
Career Progression
Sam's career has progressioned from research-focused roles to leadership positions. Notable previous roles include On Deck Longevity Biotech Fellow at On Deck, Scientific Project Manager at Vincere Biosciences, and PhD Student at Friedrich Schiller University Jena. His career trajectory demonstrates growth from research internships to management and leadership positions, with key achievements and contributions in scientific research, project management, and team leadership.
Academic Background
Sam holds a PhD from Friedrich Schiller University Jena, with a focus on scientific research and biotechnology. His academic achievements include completing research internships at renowned institutions such as the University of Liverpool, Universitair Medisch Centrum Groningen (UMCG), and AMC - Academic Medical Center.
Areas of Expertise
Sam's industry-specific skills include biotechnology, scientific research, and project management. His technical competencies encompass research design, data analysis, and scientific writing. As a leader, he possesses strong management and communication skills, with the ability to build and manage high-performing teams.
Professional Impact
Sam has contributed to various notable projects and initiatives, including driving innovation in biotechnology and contributing to the development of novel scientific solutions. His industry contributions include advancing scientific research and promoting collaboration between academia and industry.
Conclusion
Sam Sharifi's professional trajectory demonstrates growth, innovation, and leadership in the biotechnology industry. Currently, he is focused on driving scientific research and development as Chief Scientific Officer & Co-founder at multiple organizations. His value proposition lies in his ability to bridge the gap between scientific research and industry applications, with a strong focus on longevity biotech and innovative solutions.
